Solasia Pharma KK (TSE:4597) Issuance of Debt: 円0.0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4597 Solasia Pharma KK TSE:4597
71 GF Score
Price 円32.00
GF Value 円30.99
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Solasia Pharma KK Issuance of Debt?

Solasia Pharma KK TSE:4597 -11.11% 71 Issuance of Debt is 円0.0 Mil as of Jun. 2026. GuruFocus rates TSE:4597 with a GF Score™ of 71/100 and a GF Value™ of 円30.99 (Fairly Valued). The stock has 5 warning signs investors should review.

Solasia Pharma KK's Issuance of Debt for the three months ended in Jun. 2026 was 円0.0 Mil.

Solasia Pharma KK's Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2026 was 円0.0 Mil.

Solasia Pharma KK Issuance of Debt Related Terms

Solasia Pharma KK Issuance of Debt Historical Data

* Premium members only.

The historical data trend for Solasia Pharma KK's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Solasia Pharma KK Issuance of Debt Chart

Solasia Pharma KK Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 500.00 0.00 500.00 0.00

Solasia Pharma KK Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:4597
71GF Score
Solasia Pharma KK TSE:4597
Issuance of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Solasia Pharma KK Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Issuance of Debt →
What does a Issuance of Debt of 円0.0 Mil mean?
Solasia Pharma KK (TSE:4597) has a Issuance of Debt of 円0.0 Mil as of Jun. 2026. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Solasia Pharma KK and its competitors.
Is Solasia Pharma KK's Issuance of Debt too high?
Solasia Pharma KK's current Issuance of Debt is 円0.0 Mil. Overall, Solasia Pharma KK has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Solasia Pharma KK's Issuance of Debt compare to ZTS?
Solasia Pharma KK's Issuance of Debt of 円0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Issuance of Debt for a Drug Manufacturers company?
A good Issuance of Debt depends on the Drug Manufacturers industry context. However, Issuance of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Issuance of Debt mean?
A high Issuance of Debt can signal that a stock is expensive relative to its fundamentals. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Solasia Pharma KK and its competitors. Solasia Pharma KK's current Issuance of Debt is 円0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Solasia Pharma KK stock overvalued right now?
Based on GuruFocus' analysis, Solasia Pharma KK (TSE:4597) is currently considered Fairly Valued. The stock's GF Value™ is 円30.99, compared to a current price of 円32.00 — trading 3.3% above its estimated fair value. The current Issuance of Debt is 円0.0 Mil. Solasia Pharma KK's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Issuance of Debt calculated?
Issuance of Debt is calculated from a company's financial statements. For Solasia Pharma KK (TSE:4597), the current Issuance of Debt is 円0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Solasia Pharma KK (TSE:4597) Overvalued in 2026?

Based on GuruFocus' analysis, Solasia Pharma KK stock appears to be overvalued. The current stock price of 円32.00 is trading 3.3% above its estimated GF Value™ of 円30.99. GuruFocus considers Solasia Pharma KK to be Fairly Valued.

Key valuation signals for TSE:4597:

  • Issuance of Debt: 円0.0 Mil
  • GF Value™: 円30.99 vs. price of 円32.00 (3.3% above fair value)
  • GF Score™: 71/100 with 5 warning signs

No single metric tells the full story. See the TSE:4597 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Solasia Pharma KK Business Description

Other Exchanges 9SO:Germany
Address 2-1-1 Shiba Park, 4th Floor, Sumitomo Real Estate Shiba Park Tower, Minato-ku, Tokyo, JPN, 105-0011
Solasia Pharma KK develops and distributes pharmaceuticals and medical devices relating to malignant tumors.
71GF Score

Get the complete analysis for TSE:4597

Issuance of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円32.00
Price
円30.99
GF Value